Company & Sponsor Intelligence
Mayo Clinic
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials14
Recruiting3
Completed7
Countries1
Therapeutic footprint
alsautismdementia_otherepilepsymovement_disordersneuro_oncologyother_neurologyparkinsonsstrokesubstance_use
Indexed studies
NCT00577447Docosahexaenoic Acid in the Treatment of Autism
autism · United StatesNA
autism · United StatesNA
NCT07089758A Study for Cerebral Open Flow Microperfusion
neuro_oncology · United StatesNA
neuro_oncology · United StatesNA
NCT00587951The Influence of SISCOM on Intracranial Electrode Implantation in Epilepsy Surgical Candidates
epilepsy · United StatesCOMPLETED
epilepsy · United StatesCOMPLETED
NCT02372773Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
als · United StatesCOMPLETED
als · United StatesCOMPLETED
NCT07014982Remote Assessment of Digital Neurologic Testing
other_neurology · United StatesNA
other_neurology · United StatesNA
NCT05673915Study of Transcranial Direct Current Stimulation to Treat Epilepsy
epilepsy · United StatesNA
epilepsy · United StatesNA
NCT00662571Acamprosate: Genes Associated With Response
substance_use · United StatesCOMPLETED
substance_use · United StatesCOMPLETED
NCT05167721Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy
movement_disorders · United StatesPHASE2
movement_disorders · United StatesPHASE2
NCT05089682Manipulating and Optimizing Brain Rhythms for Enhancement of Sleep
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT02089217Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
other_neurology · United StatesNA
other_neurology · United StatesNA
NCT01623284PiB PET Scanning in Speech and Language Based Dementias
dementia_other · United StatesPHASE1
dementia_other · United StatesPHASE1
NCT02697292IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy
epilepsy · United StatesPHASE3
epilepsy · United StatesPHASE3
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →